Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

As Fever in Children Reaches Peak Levels, Research From Nurofen Reveals the Hidden and Wide-reaching Impact That Loss of Sleep in Children With Pain or Fever Can Have


News provided by

Nurofen

10 Dec, 2018, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, December 10, 2018 /PRNewswire/ --

Fever and pain in children can lead to lost or disrupted sleep, anxiety among the family and days of nursery, school or work missed due to illness1  

Peak level flu season occurs between December and March each year2 

New research has highlighted that sleep loss in children due to common minor ailments such as fever (e.g., caused by colds and infection), teething and sprains can have a significant impact on the child and also on the health and wellbeing of the wider family.1

New research from OnePoll funded by Nurofen's Know More Pain campaign, shows that 73% of parents or grandparents feel concerned when the child in their care misses out on a full night's sleep. Furthermore, half (50%) of parents or grandparents say they worry about themselves or other family members missing out on sleep when their child or grandchild is ill.1

Sleep is especially important for children as it directly impacts mental and physical development. During deep sleep, the blood supply to muscles is increased, energy is restored, tissue growth and repair occur, and important hormones vital for growth and development are released.3 However, children regularly suffer a wide range of minor illnesses, that can cause an interrupted night's sleep. Fever in young children is one of the most common problems faced by those caring for them.4

"As an expert in aiding sleep in babies, I know that fever can have a considerable impact on sleep for both children and their parents. Sleep is incredibly important for a baby's health and development, not to mention to help them fight their fever or illness causing the fever. For adults, a lack of sleep leads to reduced energy levels, poor concentration and memory, and mood changes - all of which can hinder their ability to look after their children and have an impact on family life in general," said Lucy Shrimpton, The Sleep Nanny. "My top tips for helping a child with fever to sleep include offering them plenty of fluids, giving them fresh air during the day, keeping the bedroom dark at bedtime, putting them to bed in light clothing, maintaining their routine if possible and giving an over the counter pain relief medicine to reduce the symptoms of fever and therefore ease sleep. Plus lots of cuddles and reassurance during the day so they feel as content as possible when going to bed!"

The Sleep Nanny continues: "Parents should try not to overcompensate with major changes to their usual nighttime 'rules' as this often sets off a whole new behavioral sleep problem (e.g., bringing child into parents' bed when that's not usually allowed). Parents might ask themselves, 'is what I'm doing helping my child to feel better or just making me feel better?'"

In addition to anxiety about lost or interrupted sleep, the research shows that many parents or grandparents are worried about the impact of the child's illness on daily life, with over half (52%) of parents or grandparents concerned about their child missing nursery or school because of illness and pain, and 35% expressing concern about having to take time off work to care for their sick child or grandchild.1

The aim of Nurofen's Know More Pain campaign is to encourage people to understand more about everyday pain and how to manage it effectively. Although effective over-the-counter remedies are readily available in pharmacies, the survey highlighted that over half (64%) of those questioned were concerned that that they don't know how to best treat children's illness.1

Nurofen for Children provides up to eight hours of pain and fever relief, to help get a full night's sleep, with one dose providing longer lasting relief than standard paracetamol.5

"Pain and fever in children, especially young children, is often distressing for parents. While much emphasis is often placed on the child, the impact on family members should not be overlooked," said Pharmacist, Terry Maguire. "Relieving pain or fever in children can alleviate some of this burden, and there are a number of options in the pharmacy that you can use. Parents should also remember that a good night's sleep also helps to support immunity, which is very important during the cold and flu season. If you are unsure about options available for your child, speak to your pharmacist."

Job code: UKNfC11180123

Date of preparation: November 2018

For media enquiries and/or interviews with Lucy Shrimpton, The Sleep Nanny, or Pharmacist, Terry Maguire, please contact sarah.moodie@havasso.com / (0)7376-802979 or eleanor.mullan@havasso.com / 020-3196-9918.

Nurofen for Children 3 months to 9 years Strawberry Oral Suspensions  

Nurofen for Children 3 months to 9 years Strawberry Oral Suspensions is for the treatment of pain and fever in children. Contains ibuprofen. Always read the label. The summary of product characteristics is available here: https://www.medicines.org.uk/emc/product/3249/smpc

About Know More Pain 

The causes of pain are complex. However, it can often be a consequence of today's busy, active lifestyles. Everyday pain has a personal impact but the ripple effect on wider family members and society is underappreciated. Nurofen understands the emotional as well as the physical burden of pain and gives you the confidence to help manage your pain effectively. If you KNOW more about pain, you can better embrace a life with one less barrier. We are striving for a world with NO more unnecessary pain. We support personal empowerment over everyday pain. #KnowMorePain

References 

1. OnePoll Know More Pain Survey. A pain management survey of 2,000 people across the UK aged over 18 years.  Survey carried out October 2018. Data on file. Survey supported by Nurofen.

2. NHS. Flu. Available from: https://www.nhs.uk/conditions/flu/ (Last accessed: November 2018).

3. Sleep Foundation. Children and Sleep. Available from: https://www.sleepfoundation.org/sleep-topics/children-and-sleep. (Last accessed: November 2018).

4. Gould et al. 2017., Fever in the Infant and Toddler. Available from: https://emedicine.medscape.com/article/1834870-overview#showall . (Last accessed: November 2018).

5. Kelley 1992 Clin Pharmacol Ther. 52(2):181-189.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.